for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Galapagos, MorphoSys Announce Initiation Of Gecko Phase 2 Study

April 24 (Reuters) - GALAPAGOS NV:

* ANNOUNCED ON TUESDAY INITIATION OF GECKO

* GECKO IS A PHASE 2 STUDY TESTING A SUBCUTANEOUS FORMULATION OF MOR106 IN COMBINATION WITH TOPICAL CORTICOSTEROIDS IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

* RECRUITMENT WILL TAKE PLACE IN THE U.S. AND CANADA

* STUDY IS INTENDED TO SERVE AS AN IND (INVESTIGATIONAL NEW DRUG) OPENER WITH THE U.S. FDA

Source text: bit.ly/2FqHED8

Further company coverage: (Gdynia Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up